[topsearch__bar__shortcode]

Tag: ALDX Stock

Phase 3 TRANQUILITY Trial Results: Aldeyra Therapeutics Inc. (ALDX) Nose Dives After Hours

Gule Rukhsar December 21, 2021

Aldeyra Therapeutics Inc. (ALDX) stock fell by 36.33% in the after-hours following the announcement of results from its TRANQUILITY trial. On December 20, ALDX shared

Aldeyra (ALDX): What Is Driving The Stock Higher?

ST Staff July 20, 2021

Aldeyra Therapeutics Inc. (ALDX) is rising today on the charts, trading up 2.18% to $9.39 per share at the last check in early trading. Aldeyra

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

Tag: ALDX Stock

Phase 3 TRANQUILITY Trial Results: Aldeyra Therapeutics Inc. (ALDX) Nose Dives After Hours

Aldeyra (ALDX): What Is Driving The Stock Higher?

Stocks
Telegraph

About

Categories

Social Links

Tag: ALDX Stock

Phase 3 TRANQUILITY Trial Results: Aldeyra Therapeutics Inc. (ALDX) Nose Dives After Hours

Aldeyra (ALDX): What Is Driving The Stock Higher?

Stocks Telegraph

About

Categories

Social Links

Stocks
Telegraph